Roivant
2 known investors
Roivant develops medicines and healthcare technologies by creating and operating focused biopharmaceutical subsidiaries called "Vants" that span drug discovery, development, and commercialization. The company applies technology across the pharmaceutical value chain and reports multiple Phase 3 trial successes and FDA approvals.
AI & Machine LearningBiotechHealthtech
Investors Β· 2
Frequently asked questions
- What does Roivant do?
- Roivant develops medicines and healthcare technologies by creating and operating focused biopharmaceutical subsidiaries called "Vants" that span drug discovery, development, and commercialization. The company applies technology across the pharmaceutical value chain and reports multiple Phase 3 trial successes and FDA approvals.
- Who are Roivant's investors?
- Roivant's investors include Commonweal Ventures, SoftBank Vision Fund.